Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes

التفاصيل البيبلوغرافية
العنوان: Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes
المؤلفون: Jaw-Yuan Wang, Wei-Chih Su, Hsiang-Lin Tsai, Hsiu-Chung Cheng, Tsung-Kun Chang
المصدر: Translational Oncology, Vol 14, Iss 7, Pp 101089-(2021)
Translational Oncology
بيانات النشر: Elsevier BV, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Oncology, endocrine system diseases, TCF4, Transcription factor 4, Colorectal cancer, RR, relative risk, Review, I2, I-square, HbA1c, Hemoglobin A1c, ADM, antidiabetic medications, AGEs, advanced glycation end-products, SMAD3, Mothers against decapentaplegic homolog 3, US, United States, Impaired glucose tolerance, ADA, American Diabetes Association, Diabetes mellitus, 0302 clinical medicine, GREM1, Gremlin 1, SEPT9, septin 9, RC254-282, APC, Adenomatous polyposis coli, pCR, pathologic complete response, RFS, recurrence-free survival, Metformin, 030220 oncology & carcinogenesis, CRC, colorectal cancer, TCF7L2, Transcription Factor 7 Like 2, medicine.medical_specialty, CSCs, cancer stem cells, WNT, Wingless-related integration site, mTOR, mammalian target of rapamycin, BMI, Body mass index, GLUT1, glucose transporter 1, STZ, streptozotocin, EHMT2, Euchromatic Histone Lysine Methyltransferase 2, VEGFR2, vascular endothelial growth factor 2, mCRC, metastatic colorectal cancer, 03 medical and health sciences, NIDDM, non-insulin-dependent diabetes mellitus, PFS, Progression-free survival, ERFC, Emerging Risk Factors Collaboration, PKC, protein kinase C, KRAS, Kirsten rat sarcoma viral oncogene homolog, AKT, RAC-alpha serine/threonine-protein kinase, WFS1, Wolframin ER Transmembrane Glycoprotein, IGF, Insulin-Like Growth Factor, nutritional and metabolic diseases, medicine.disease, PPARG, Peroxisome Proliferator Activated Receptor Gamma, 030104 developmental biology, Hyperglycemia, TCF7L2, Oncological outcome, 0301 basic medicine, Cancer Research, TP53, tumor protein p53, FOLFOX, Folinic acid, Fluorouracil, Oxaliplatin, RPG, random plasma glucose, Cancer risk, DNA, deoxyribonucleic acid, DM, diabetes mellitus, HNF1B, Hepatocyte nuclear factor-1-beta, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, HR, hazard ratios, CENTRAL, Cochrane Central Register of Controlled Trials, GWAS, Genome-wide association studies, IGF1, Insulin-Like Growth Factor 1, HBP, hexosamine biosynthetic pathway, medicine.drug, PI3K, Phosphoinositide 3-kinases, KCNQ1, Potassium Voltage-Gated Channel Subfamily Q Member 1, EMT, epithelial mesenchymal transition, CAMK1D, Calcium/Calmodulin Dependent Protein Kinase ID, TTR, the time to recurrence, 2-h PG, 2-h plasma glucose, OS, overall survival, ROS, reactive oxygen species, IGFBPs, insulin-like growth factor-binding protein, Internal medicine, RAS, Rat sarcoma, medicine, FPG, fasting plasma glucose, PI3K/AKT/mTOR pathway, VTI1A, Vesicle Transport Through Interaction With T-SNAREs 1A, U.S.FDA, United States Food and Drug administration, OGTT, Oral Glucose Tolerance Test, business.industry, IGF2BP2, Insulin Like Growth Factor 2 MRNA Binding Protein 2, ACF, aberrant crypt foci, AMPK, Cancer, BMJ, British Medical Journal, CI, confidence interval, OR, odds ratio, AMPK, AMP-activated protein kinase, DKD, diabetic kidney disease, TP53INP1, Tumor Protein P53 Inducible Nuclear Protein 1, 5-FU, 5-fluorouracil, NEJM, The New England Journal of Medicine, business
الوصف: Highlights • Diabetes mellitus and hyperglycemia significantly affect the incidence and prognosis of colorectal cancer. • Evidence of the effects of metformin remain controversial in cancer prognosis. • Potential molecular mechanisms by which DM and hyperglycemia affects cancer risk. • Potential roles of glucose modulation in CRC therapy.
Diabetes mellitus (DM) and hyperglycemia have been shown to have significant effects on the incidence, chemoresistance, and prognosis of colorectal cancer (CRC), as well as the outcomes of localized and metastatic CRC. Inflammation and endocrine effects may act as central mechanisms of DM and cancer and stimulate the insulin‐like growth factor 1–phosphoinositide 3-kinase–Akt–mammalian target of rapamycin (IGF-1–PI3K–AKT–mTOR) pathway. Dysregulation of the AMP-activated protein kinase (AMPK) pathway leads to metabolic imbalance and indicates cancer risk. The use of metformin for chemoprevention has been shown to reduce CRC and adenoma incidence through the upregulation of AMPK, which causes cell cycle arrest in the Gap 1–S (G1–S) phase and inhibits the mTOR pathway, even potentially reversing the epithelial–mesenchymal transition. However, evidence of the effects of metformin remain controversial in cancer prognosis. Several genes, such as transcription factor 7-like 2(TCF7L2), tumor protein P53 inducible nuclear protein 1(TP53INP1), gremlin 1 (GREM1), and potassium voltage-gated channel subfamily Q member 1(KCNQ1), are pleiotropically related to DM as well as cancer risk and prognosis. Epigenetic modification of members of the Let-7 family such as miR-497, miR-486, and miR-223 is strongly associated with impaired glucose tolerance and CRC risk. Herein we review the pathophysiological and epidemiological evidence as well as potential underlying molecular mechanisms by which DM and hyperglycemia affect CRC risk. We also suggest potential roles of glucose modulation in CRC therapy and propose an agenda for future research and clinical practice.
Graphical abstract Image, graphical abstract
تدمد: 1936-5233
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b748b9c71d9b30a48c845ddaf0de4297Test
https://doi.org/10.1016/j.tranon.2021.101089Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....b748b9c71d9b30a48c845ddaf0de4297
قاعدة البيانات: OpenAIRE